Cardiotoxicity in breast cancer treatment: Causes and mitigation-Reference-Cited by-同舟云学术

Cardiotoxicity in breast cancer treatment: Causes and mitigation

Published:2023 Issue: Volume:37 Page:100760
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Valiyaveettil Deepthi,Joseph Deepa,Malik Monica

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference129 articles.

1. The role of cardioprotection in cancer therapy cardiotoxicity: JACC: CardioOncology state-of-the-art review;Omland;JACC CardioOncology,2022

2. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management;Curigliano;CA Cancer J. Clin.,2016

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet (London, England),2012

4. Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance;Carver;Seminars Oncol.,2013

5. Creating a biomarker panel for early detection of chemotherapy related cardiac dysfunction in breast cancer patients;Srikanthan;J. Clin. Experim. Cardiol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: the paradigm of radiotherapy;Pharmacology & Therapeutics;2024-08

2. Protective effects of exercise on cardiotoxicity induced by breast cancer treatments: A systematic review and meta-analysis;Maturitas;2024-05

3. Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan;Diagnostics;2023-11-28